|
· Lead field-based medical activities for the digital therapeutics portfolio, which includes deprexis (for management of depression) and vorvida (for management of problematic or harmful alcohol consumption).
· Serve as a subject matter expert on clinical and scientific matters related to mental health and substance use disorders, digital therapeutics and artificial intelligence, and psychotherapeutic approaches to care.
· Provide cross-functional support to marketing, market access, and sales teams in order to educate internal and external stakeholders on digital therapeutics for mental health and substance use disorders.
· Partner with health care providers, health systems, advocacy groups, and professional organizations to present educational information on digital mental health, foster networking opportunities among professionals in the field, and facilitate opportunities for business development.
Lead development and execution of real-world research and implementation science protocols.
Lead development of medical affairs resources for deprexis and vorvida.
Provide internal guidance and expertise to all levels of the organization, including to senior leadership.
|
|
· Served as a medical affairs expert regarding use of extracorporeal photopheresis (ECP) in cutaneous T-cell lymphoma (CTCL), graft-versus-host disease (GvHD), solid organ transplantation, and systemic sclerosis.
· Identified, created, and managed relationships with KOLs with expertise in CTCL, acute and chronic GvHD, solid organ transplantation, and systemic sclerosis.
· Collaborated cross-functionally with global colleagues in the US, Europe, and Australia to provide scientific and medical support for commercial, clinical, and health economics projects.
Responded to requests for medical information related to Therakos ECP.
Collected scientific and clinical insights to inform medical strategy and tactics.
Maintained scientific communications role and responsibilities after moving into the MSL role, which included:
o Leading publication strategy for Therakos ECP in collaboration with the global medical affairs team.
o Overseeing development of publications, digital scientific platforms, and field reactive slide decks.
o Developing a cross-company patient-centered publication strategy.
|
|
· Served as strategic and subject matter expert for four established brands across three therapeutic areas (i.e., psychiatry, neurology, and gastroenterology).
· Directed content development for scientific communications and medical education initiatives.
· Managed relationships with key opinion leaders (KOLs) across therapeutic areas, including through field-based activities as the company did not have a dedicated MSL team.
· Led medical assessment of business development and indication expansion opportunities, including development of target product profiles and contribution to forecast models.
· Led project management and maintained the project dashboard for the Medical Affairs Department.
|
|
Messina AJ, O’Brien QE, Andrianov V, Moss KR, Vidal-Fisher L. Under Reporting of Patient Reported
Outcomes (PROs) in Myeloproliferative Neoplasm (MPN) Clinical Trials. Poster presented at: 61st Annual Meeting of the American Society of Hematology; December 2019; Orlando, FL.
O’Brien QE, Lotrecchiano GR. Applying Team Science Principles to Biomedical Publications Teams: Understanding Team Effectiveness. Poster presented at: 10th Annual International Science of Team Science Conference; May 2019; Lansing, MI.
O’Brien QE, Scully J, Hegarty J. Understanding primary care providers’ and general neurologists’ interest in and need for education on Alzheimer’s Disease management. Poster presented at: 46th North American Primary Care Research Group (NAPCRG) Annual Meeting; November 2018; Chicago, IL.
Mattingly G, Jain R, O’Brien QE, Hegarty J. Investigation of Clinical Practice Challenges in the Management of ADHD. Poster presented at: American Professional Society of ADHD and Related Disorders; January 2018; Washington, DC.
O’Brien QE, Scully J, Rappa E, Smith PK, Hegarty J. Defining the Need for Better Tools and Education on Tacrolimus Intrapatient Variability to Improve Outcomes for Transplant Patients. Poster presented at: American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting; December 2017; Orlando, FL.
Jain R, Mattingly G, Pikalov A, O’Brien QE, Scully J, Smith L, Sender D, O’Brien K, Hegarty J. Unmet Needs in the Treatment of Pediatric and Adult ADHD. Poster presented at: Psych Congress; September 2017; New Orleans, LA.
O’Brien QE, Smith PK, Sender D, Hegarty J. Practice Perspectives on Telepsychiatry Use. Poster presented at: U.S. Psychiatric and Mental Health Congress; October 2016; San Antonio, TX.
O’Brien QE, Downs S, Graziose M, Fanzo J. Assessing Nutrition Knowledge Gaps and IYCF Practices of Mothers in Rural Senegal: A Formative Assessment for Nutrition Education. Oral presentation at: Mailman School of Public Health Student Research Diversity Day; May 2015; New York, NY.
|
